To: richardred  who wrote (5833 ) 2/25/2020 12:11:18 PM From: richardred     Respond to    of 7239  RE-ENZ-Speculation   Looks like we finally might have a resolution!                           Shareholders Support the Election of Both HDF Nominees to Enzo Board of Directors                                                               Preliminary Vote Count Indicates Shareholders Have Rejected Company’s Proposal to Expand Size of Board                                                                          February 25, 2020 10:27 AM Eastern Standard Time                          BIRMINGHAM, Ala.--( BUSINESS WIRE )--Harbert  Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP  (collectively “HDF”), the beneficial owners of more than 11.8% of the  outstanding shares of Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the  “Company”), today announced that, based on a preliminary vote count  provided by its proxy solicitor, Enzo shareholders voted to elect HDF  nominees, Fabian Blank and Peter Clemens, and Company nominee Rebecca  Fischer, to the Board of Directors (the “Board”) at the Company’s 2019  Annual Meeting of Shareholders (the “Annual Meeting”) today.    The preliminary results also indicate that shareholders rejected the  Company’s proposal to amend the Enzo’s bylaws to increase the size of  the Board.    Commenting on the preliminary results of the Annual Meeting, Kenan Lucas, Managing Director and Portfolio Manager of HDF said:    “We are extremely pleased and grateful for the overwhelming support from  shareholders for electing our two independent, highly-qualified  nominees to the Board. We believe the addition of Fabian and Peter to  the Board is a crucial step to putting Enzo on the path to value  creation as well as working towards the corporate governance  enhancements the Company so desperately needs. We look forward to the  Board working to help Enzo reach its full potential.”    About Harbert Discovery Fund (HDF)     HDF invests in a concentrated portfolio of publicly traded small  capitalization companies in the US and Canada. We perform significant  due diligence on each portfolio company prior to investing. In addition  to researching all publicly available information and meeting with  management, our diligence includes substantial primary research with  industry experts, consultants, bankers, customers and competitors. We  often spend months or years researching ideas before making an  investment decision and we only invest in companies that we believe are  significantly undervalued, and where there is the potential for change  to enhance or accelerate value creation. In an effort to unlock this  potential value, we seek to work directly with the boards and management  teams of our portfolio companies privately and collaboratively,  engaging with them on a range of factors including governance, board  composition, corporate strategy, capital allocation, strategic  alternatives and operations. We have effected positive, fundamental  changes at our current and past investments through this  behind-the-scenes, constructive approach. HDF currently has board  representation at three of our portfolio companies. In each case,  changes to the board were agreed upon privately and it is our strong  preference in every investment to avoid the unnecessary distractions and  costs of a public proxy campaign.    About Harbert Management Corporation (HMC)     HMC is an alternative asset management firm with approximately $7.0  billion in regulatory assets under management as of December 31, 2019.  HMC currently sponsors nine distinct investment strategies with  dedicated investment teams. Additional information about HMC can be  found at  www.harbert.net .                                       Contacts            Investor Contact    Okapi Partners LLC  Bruce Goldfarb / Chuck Garske / Jason Alexander, 212-297-0720   info@okapipartners.com     Media Contact    Sloane & Company  Dan Zacchei / Sarah Braunstein, 212-486-9500   dzacchei@sloanepr.com  /  sbraunstein@sloanepr.com businesswire.com